Although VCAM-1 may be considered pharmacologically associated with stroke, it is closely involved in the progression of inflammatory and autoimmune disorders, including atherosclerosis, rheumatoid arthritis, multiple sclerosis, organ allografts, asthma, transplant rejection, and cancer [29,30]. The gene discussed is VCAM1; the disease is stroke disorder.